![Jay Mitchell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Mitchell
Directeur Technique/Scientifique/R&D chez
CLIMB BIO, INC.
Profil
Jay Mitchell is Vice President-Clinical Operations at Climb Bio, Inc. since 2024.
Education includes an undergraduate degree from the University of Memphis and an MBA from the University of Mississippi.
Postes actifs de Jay Mitchell
| Sociétés | Poste | Début |
|---|---|---|
| CLIMB BIO, INC. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
Formation de Jay Mitchell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Memphis
 University of Memphis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
 University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
